MARGARET SCHRADER: Open Payments
NPI 1437878055 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$778 in 37 payments from 21 companies in 2025. Trend: 2023 $1,123 · 2024 $1,611 · 2025 $778
Food & beverage: $778
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | 1 | $129 |
| ABBVIE INC. | 5 | $95 |
| Lilly USA, LLC | 4 | $74 |
| PFIZER INC. | 4 | $68 |
| Corcept Therapeutics | 3 | $64 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $41 |
| GlaxoSmithKline, LLC. | 2 | $29 |
| Amgen Inc. | 1 | $27 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
Products named: Korlym, QULIPTA, Kerendia, NURTEC ODT, MOUNJARO, OTEZLA, LEQVIO, NEXLETOL.
Industry payments across IN — which companies pay providers there.
